Study shows that doctors with personal experience of cancer are more likely to act against established guidelines to recommend that low-risk women receive ovarian cancer screening.
Electronic Health Records are intended to streamline and improve access to information -- and have been shown to improve quality of care -- but a new study shows they also leave both doctors and patients unsatisfied, even after full implementation.
A new national study has found that inducing labor in first-time mothers at 39 weeks can help prevent cesarean births and high blood pressure. The University of Texas Medical Branch participated in the study and Dr. George Saade, chief of obstetrics and the principal investigator at UTMB, said that babies born to women induced at 39 weeks did not have worse outcomes compared to those who were not induced at 39 weeks.
Inducing labor in healthy first-time mothers in the 39th week of pregnancy results in lower rates of cesarean sections compared with waiting for labor to begin naturally at full term, according to a multicenter study funded by the National Institutes of Health (NIH). Additionally, infants born to women induced at 39 weeks did not experience more stillbirths, newborn deaths or other major health complications.
Inducing labor in healthy women at 39 weeks into their pregnancy reduces the need for cesarean section and is at least as safe for mother and baby as waiting for spontaneous labor. Choosing to induce could also reduce the risk that mothers will develop preeclampsia and that newborns will need respiratory support after delivery, according to a study publishing in the New England Journal of Medicine.
For many years, obstetricians counseled women that inducing labor increased the likelihood of a cesarean birth, although there was no solid evidence in clinical trials to support that. Now, a large national study shows electively inducing labor at 39 weeks actually reduces the rate of cesarean deliveries and decreases maternal and fetal complications. Newborns have fewer respiratory problems. Women report less labor pain, have lower rates of preeclampsia and gestational hypertension.
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form of a blood pressure disorder has added to evidence that the condition -- known as preeclampsia -- mainly damages the heart's ability to relax between contractions, making the organ overworked and poor at pumping blood.
The genetic screening of fertilized eggs for embryo selection in assisted reproduction makes no difference to live birth rates, according to results from the largest published study of its kind. Results from this multicenter randomized controlled trial are reported today in the journal Human Reproduction and, say the authors, confirm the 'widely accepted' view that preimplantation genetic testing for chromosome abnormality (PGT-A) will not increase live birth rates in IVF.
More than one in 10 babies worldwide are born prematurely, according to the World Health Organization. Now scientists report in ACS Biomaterials Science & Engineering that they have developed an organ-on-a-chip that could help explain why. The device, which replicates the functions of a key membrane in the placenta, could lead to a better understanding of how bacterial infections can promote preterm delivery. It could also lead to new treatments for this condition.
Women who take epilepsy drugs while they are pregnant may have a lower risk of having a child with delays in language skills if they take folic acid supplements before and early in pregnancy, according to a study published in the Aug. 1, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.